undamentalytics Newsletter

Wainer Andrea F: insider trades

Officer at Abbott Laboratories. No open-market purchases and 18 sales not made under a pre-set plan, reported from June 24, 2019 to March 4, 2025.

What happened after Wainer Andrea F’s sales?

After their sales, the shares moved −7.1% against the index over 12 months on average (a negative figure means selling was the right call); 89% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Wainer Andrea F: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 18 −4.7% −5.6% 78% 6 −1.69 0.15 No reliable evidence
Sales, 12 months after the report 18 −7.1% −6.8% 89% 6 −1.96 0.11 No reliable evidence
Sales, 12 months after the trade 18 −7.5% −7.1% 83% 6 −1.80 0.13 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Abbott Laboratories ABT RETIRED EVP018June 24, 2019March 4, 2025

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
March 4, 2025March 3, 2025 ABT Sale $131,123 −5.5%−35.6%−36.6%
May 3, 2023May 2, 2023 ABT Sale $909,467 −13.1%−32.1%−27.8%
March 2, 2023March 1, 2023 ABT Sale $68,375 −6.0%−11.7%−11.9%
March 2, 2022March 1, 2022 ABT Sale $53,867 +1.4%−7.9%−5.6%
December 28, 2021December 23, 2021 ABT Sale $2,247,500 −10.8%−2.2%−3.6%
December 21, 2021December 17, 2021 ABT Sale $1,031,550 −11.6%−3.7%−4.9%
December 15, 2021December 13, 2021 ABT Sale $1,957,500 −5.6%−3.9%−4.0%
December 8, 2021December 6, 2021 ABT Sale $596,250 −4.1%−3.1%−7.4%
November 17, 2021November 15, 2021 ABT Sale $1,625,125 −0.9%−2.8%−5.5%
September 3, 2021September 2, 2021 ABT Sale $1,211,250 +1.6%−6.5%−6.7%
August 19, 2021August 17, 2021 ABT Sale $1,812,500 −4.9%−8.1%−8.1%
March 5, 2021March 3, 2021 ABT Sale $755,098 −15.5%−7.0%−13.8%
March 2, 2021March 1, 2021 ABT Sale $70,798 −20.5%−13.8%−13.4%
October 1, 2020September 30, 2020 ABT Sale $3,210,300 −8.1%−20.1%−19.8%
September 25, 2020September 23, 2020 ABT Sale $374,016 −8.3%−16.2%−15.5%
March 3, 2020March 2, 2020 ABT Sale $111,305 +11.4%+20.9%+25.1%
February 11, 2020February 7, 2020 ABT Sale $99,243 +20.3%+27.1%+24.1%
June 24, 2019June 21, 2019 ABT Sale $101,134 −4.0%−1.3%+0.3%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Wainer Andrea F traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.